Vancouver’s Precision NanoSystems announced today the location of its new Genetic Medicine GMP Biomanufacturing Center in Vancouver.
Precision NanoSystems will expand its global headquarters with a 75,000-square-foot facility currently under construction and slated for completion in Q4 2022.
The new site will be located at 1055 Vernon Drive, in the Evolution Block building, in the False Creek Flats area of Vancouver. PNI’s new genetic medicine GMP Biomanufacturing Centre will also be housed at the site.
Precision NanoSystems received a contribution of $25.1 million through the Strategic Innovation Fund (SIF) earlier this year to support the $50.2-million biomanufacturing centre project.
Precision NanoSystems provides technology solutions enabling the development and manufacturing of lipid nanoparticles, critical for the delivery of genetic medicines, including mRNA.
The biomanufacturing centre will support PNI’s client base of leading drug developers through clinical development, as well as Canada’s efforts for future pandemic preparedness through the manufacture of RNA vaccines.
Earlier this summer Precision NanoSystems was acquired by Danaher Corporation’s Life Sciences platform.